Supply Chain

Health systems will see a 7.35 percent price increase for drug purchases through mid- 2019, according to estimates from Vizient's January 2018 Drug Price Forecast.

Effective Feb. 5, Bob Hugin, executive chairman of pharmaceutical giant Celgene, will step down, according to Street Insider.

As the nation grapples with a widespread flu outbreak and states continue to see spikes in flu activity, some pharmacies throughout Florida are struggling to keep up with the demand of the antiviral drug Tamiflu, reports the Orlando Sentinel.

The FDA granted approval Friday to Advanced Accelerator Applications for its drug Lutathera, which treats cancer that affects the pancreas or gastrointestinal tract.

U.S. physicians indicate an almost 50-50 split when asked whether trackable pills will improve patient outcomes, according to a recent survey by SERMO, a global social network for physicians.

Teva Pharmaceuticals will close its manufacturing plant in Manati, Puerto Rico, which will eliminate approximately 200 jobs, according to a STAT Pharmalittle newsletter.

A majority of U.S. workers feel confident they won't lose their jobs to automation, despite increased adoption among major companies, according to a survey from The Marist Poll and NPR.

Abbott Laboratories' net sales rose 42.3 percent to $7.59 billion in the fourth quarter ending Dec. 31, beating revenue projections of $7.39 billion, reports CNBC.

Baxter International, a saline bag supplier, issued an update Wednesday to customers on its efforts to mitigate shortages of saline products as the U.S. grapples with a severe flu season that is dramatically increasing demand, reports Reuters.

Here are seven articles Becker's Hospital Review published in the last week, highlighting the FDA's decision to extend the shelf life of several IV solutions in short supply and Congress' two-year delay of the medical device tax, among other topics.